Mutations in these genes confer specific phenotypic profiles to patients with dementia: amyloidogenic pathology associated with APP, PSEN1, and PSEN2 mutations and tauopathy associated with MATP mutations, representing the two major pathogenic hypotheses for AD [9, 26–28]. This evidence concerns the gene PSEN1 and dementia.